Lund based startup Asgard Therapeutics has reported they have been awarded the second step of Vinnova’s Innovative Startup program in order to further develop a new cancer immunotherapy based on dendritic cell reprogramming. Cancer remains one of the major challenges to modern society affecting one third of all people in Europe. Cancer immunotherapies use the … Continue reading Asgard Therapeutics awarded Vinnova’s Innovative Startup Step 2